These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25996046)

  • 61. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
    Dohmen C; Wagner E
    Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell.
    Lönn P; Dowdy SF
    Expert Opin Drug Deliv; 2015; 12(10):1627-36. PubMed ID: 25994800
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cell-Penetrating Peptides Delivering siRNAs: An Overview.
    Falato L; Gestin M; Langel Ü
    Methods Mol Biol; 2021; 2282():329-352. PubMed ID: 33928583
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA.
    Ullah I; Chung K; Beloor J; Kim J; Cho M; Kim N; Lee KY; Kumar P; Lee SK
    J Drug Target; 2017 Apr; 25(4):320-329. PubMed ID: 27820977
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
    Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
    J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histidine-Rich Cationic Cell-Penetrating Peptides for Plasmid DNA and siRNA Delivery.
    Kichler A; Mason AJ; Marquette A; Bechinger B
    Methods Mol Biol; 2019; 1943():39-59. PubMed ID: 30838608
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
    Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
    Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes.
    Oliveira S; van Rooy I; Kranenburg O; Storm G; Schiffelers RM
    Int J Pharm; 2007 Mar; 331(2):211-4. PubMed ID: 17187949
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies.
    Habault J; Poyet JL
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866424
    [TBL] [Abstract][Full Text] [Related]  

  • 72. siRNA-loaded poly(histidine-arginine)
    Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
    Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Challenge to overcome current limitations of cell-penetrating peptides.
    Kim GC; Cheon DH; Lee Y
    Biochim Biophys Acta Proteins Proteom; 2021 Apr; 1869(4):140604. PubMed ID: 33453413
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate.
    Peng J; Rao Y; Yang X; Jia J; Wu Y; Lu J; Tao Y; Tu W
    Neurosci Lett; 2017 May; 650():153-160. PubMed ID: 28450191
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Current status of non-viral vectors for siRNA delivery].
    Yang FF; Huang W; Li YF; Gao ZG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cell penetrating peptides: A concise review with emphasis on biomedical applications.
    Derakhshankhah H; Jafari S
    Biomed Pharmacother; 2018 Dec; 108():1090-1096. PubMed ID: 30372809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cell-penetrating peptides (CPPs): From delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis.
    Rádis-Baptista G; Campelo IS; Morlighem JRL; Melo LM; Freitas VJF
    J Biotechnol; 2017 Jun; 252():15-26. PubMed ID: 28479163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.